RxDoctor Payments Data

Melodie Duff, APRN

Family · El Reno, OKNPI 1497150387

Payments from drug & device makers

$539in general payments, 2019–2025

Across 30 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$163
  • Sanofi-aventis U.S. LLC$70
  • Otsuka America Pharmaceutical, Inc.$50
  • Boehringer Ingelheim$48
  • AstraZeneca$41
  • Lundbeck LLC$40
  • plus $127 from 7 others

What the payments were for

  • Food & beverage$539100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$539 in reported general payments places this provider in the 55th percentile of 2,026 family providers in Oklahoma.

See all family providers in Oklahoma

Medicare billing

Part B allowed, 2024
$5,667
Medicare patients
36
Services billed
359

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$5,166
Duloxetine Hcl20$319
Albuterol Sulfate HfaAlbuterol Sulfate18$279
Omeprazole19$185
Levothyroxine Sodium28$184
Metoprolol Succinate16$169
Metformin Hcl25$163
Ibuprofen14$146
Metoprolol Tartrate15$129
Lisinopril26$128
Bupropion Hcl11$111
Dicyclomine Hcl12$111
Atorvastatin Calcium15$86
Venlafaxine Hcl ErVenlafaxine Hcl13$45
Amlodipine Besylate13$44

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$17$5,16611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,026 family providers in Oklahoma.

Other family in El Reno

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →